Comparison of roxithromycin with co-amoxiclav in patients with sinusitis.

@article{Chatzimanolis1998ComparisonOR,
  title={Comparison of roxithromycin with co-amoxiclav in patients with sinusitis.},
  author={E Chatzimanolis and Nina Ajmone Marsan and Dimitrios Lefatzis and Antonis Pavlopoulos},
  journal={The Journal of antimicrobial chemotherapy},
  year={1998},
  volume={41 Suppl B},
  pages={81-4}
}
In an open, randomized study of 60 patients with acute or recurrent sinusitis, the bacteriological and clinical efficacy of roxithromycin 150 mg bd were compared with those of po co-amoxiclav (625 mg) tds. Of 52 patients who underwent sinus puncture for isolation of causative organisms, 48 had pathogens sensitive to both antibiotics. Satisfactory clinical… CONTINUE READING